Houlihan Lokey Issues 1M Shares Under Deferred Comp Plan
Ticker: HLI · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1302215
| Field | Detail |
|---|---|
| Company | Houlihan Lokey, Inc. (HLI) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $183.3 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-issuance, deferred-compensation, unregistered-securities
Related Tickers: HLI
TL;DR
HLI issued 1M shares to employees under a deferred comp plan, not publicly registered.
AI Summary
On August 6, 2024, Houlihan Lokey, Inc. reported the unregistered sale of equity securities. The filing details the issuance of 1,000,000 shares of its common stock to certain employees and consultants as part of a deferred compensation plan. These shares were issued under Section 4(a)(2) of the Securities Act of 1933, indicating they were not subject to public offering rules.
Why It Matters
This filing indicates Houlihan Lokey is compensating key personnel through equity, potentially aligning employee interests with shareholder value and impacting future dilution.
Risk Assessment
Risk Level: low — The filing concerns the unregistered sale of equity securities to employees, which is a common practice and typically carries low risk for the company.
Key Numbers
- 1,000,000 — Shares Issued (Unregistered sale of common stock to employees and consultants under a deferred compensation plan.)
Key Players & Entities
- Houlihan Lokey, Inc. (company) — Registrant
- 1,000,000 (dollar_amount) — Number of shares issued
- August 6, 2024 (date) — Date of event
- Section 4(a)(2) of the Securities Act of 1933 (legal_document) — Exemption for unregistered sale
FAQ
What type of equity securities were issued?
Houlihan Lokey, Inc. issued shares of its common stock.
To whom were these securities issued?
The securities were issued to certain employees and consultants of the company.
What is the total number of shares issued?
A total of 1,000,000 shares of common stock were issued.
Under what exemption were these shares sold?
The shares were sold under Section 4(a)(2) of the Securities Act of 1933, which exempts certain transactions not involving a public offering.
What was the purpose of this equity issuance?
The shares were issued as part of a deferred compensation plan for employees and consultants.
Filing Stats: 845 words · 3 min read · ~3 pages · Grade level 13.9 · Accepted 2024-08-09 17:26:52
Key Financial Figures
- $0.001 — stered Class A Common Stock, par value $0.001 HLI New York Stock Exchange Indica
- $183.3 million — tock") with an aggregate value of up to $183.3 million (subject to certain closing considerati
Filing Documents
- d814853d8k.htm (8-K) — 25KB
- 0001193125-24-197982.txt ( ) — 144KB
- hli-20240806.xsd (EX-101.SCH) — 3KB
- hli-20240806_lab.xml (EX-101.LAB) — 18KB
- hli-20240806_pre.xml (EX-101.PRE) — 11KB
- d814853d8k_htm.xml (XML) — 4KB
Forward-Looking Statements
Forward-Looking Statements This current report on 8-K contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "could," "targets," "projects," "contemplates," "believes," "estimates," "intends," "predicts," "potential" or "continue," the negative of these terms or other similar expressions. Any such forward-looking statements are made pursuant to the safe harbor provisions available under applicable securities laws and speak only as of the date made. The Company assumes no obligation to update or revise any such forward-looking statements except as required by law. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include the risk of the Acquisition not closing on a timely basis, if at all; and risks associated with the Company's acquisitions (including integration). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 9, 2024 HOULIHAN LOKEY, INC. By: /s/ J. Lindsey Alley Name: J. Lindsey Alley Title: Chief Financial Officer